Unintended Impact of US Food and Drug Administration Recalls on the Use of Contaminated and Non-Contaminated Angiotensin Receptor Blockers Among Medicaid Beneficiaries

Abstract

Get full access to this article

View all access options for this article.

References

US Food and Drug Administration. Recalls, market withdrawals, & safety alerts. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts. Accessed June 11, 2019.

Byrd

Chertow

Bhalla

Hypertension hot potato—anatomy of the angiotensin-receptor blocker recalls. N Engl J Med. 2019;380:1589-1591. doi:10.1056/NEJMp1901657

Gunasekaran

Chertow

Bhalla

Byrd

JB.

Current status of angiotensin receptor blocker recalls. Hypertension. 2019;74:1275-1278. doi:10.1161/HYPERTENSIONAHA.119.13955

Jackevicius

Krumholz

Chong

, et al. Population impact of generic valsartan recall. Circulation. 2020;141:411-413. doi:10.1161/CIRCULATIONAHA.119.044494

Al-Kindi

Oliveira

GH.

Abrupt increase in reporting of neoplasms associated with valsartan after medication recall. Circ Cardiovasc Qual Outcomes. 2019;12:e005536. doi:10.1161/CIRCOUTCOMES.119.005536